Grishma Pawar, PhD, NanoVation Therapeutics^TM Scientist II in Preclinical, and Jessica Silva, a Preclinical Immunology Scientist at NanoVation Therapeutics^TM, participated in the 2023 International Society for Vaccines – ISV Annual Congress in Lausanne earlier this week.

Jessica presented a remarkable poster on “Development of Novel and Robust LNP-RNA Vaccines.” Her valuable contributions continue to drive innovation in the field of immunology.